Academic Editor: Peter A. McCullough
Dear Editor,
The SARS-CoV-2 virus is transmitted directly or transported in the form of aerosol droplets and comes into contact with the nasal and oropharyngeal mucosa where it begins to proliferate. From here, the infection spreads to the oropharynx and other respiratory organs through a mechanism called “microaspiration” [1].
As recently illustrated by McCullough et al. [2], COVID-19 disease requires early intervention that can stem hospitalizations and deaths. Its progression can be arrested if the virus is destroyed during incubation [3]. Accordingly, initial multiple therapy [2] may include nasal instillations and gargling with Povidone-Iodine (PVP-I), a soluble form of iodine, known to be a powerful virucidal. PVP-I-based gargles and nasal instillations have been shown to lower the nasopharyngeal viral load in patients with COVID-19 [4].
A 70-year-old female subject presented fever which reached 38
This survey, although limited to a single patient, can provide useful information on how the advanced stage of COVID-19 can rapidly regress even after nasal instillations and gargles of a 1% solution of PVP-I.
This uncommon course is in accordance with many in vitro
studies, demonstrating the rapid virucidal activity of PVP-I on
multiple viruses, including related coronaviruses [5], owing to the action of the
released I
The mode of action of PVP-I is independent of the type of coronavirus variant that could arise, and hence, it could be included in future armamentarium for the prevention and treatment of the COVID-19 epidemic [6].
Cases of both overt and subclinical hypothyroidism following prolonged oral rinses with PVP-I have been reported, and hence, its use is contraindicated in patients with active thyroid disease.
Therapies such as Povidone-iodine are also widely available, generic and inexpensive. Naturally, its effectiveness must be verified through clinical research, including randomized trials. Until such evidence is available, its promising co-use in early intervention could be considered experimental without supplanting either personal protective equipment or the acquisition of immunity through vaccines [7].
Not applicable.
I would like to express my gratitude to all those who helped me during the writing of this manuscript.
This research received no external funding.
The author declares no conflict of interest.